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Diagnosis and Management of Enteric
Disease and Abdominal Catastrophe in
Peritoneal Dialysis Patients With Peritonitis
Mark D. Faber and Jerry Yee
Peritoneal dialysis (PD)–associated peritonitis rates have decreased significantly in recent years,
especially Staphylococcus epidermidis and Staphylococcus aureus infections. Rates of gram-negative, polymicrobial, and fungal peritonitis have remained steady. The reported mortality of gramnegative and polymicrobial peritonitis varies widely (4%-50%). Most likely, the reason for this
variability is that prognosis depends on the underlying etiology more than the specific microorganisms isolated. Gram-negative, polymicrobial, and fungal infection have variable association with
documented visceral disease, and the highest mortality occurs in reports with the highest prevalence
of intra-abdominal pathology. The odds ratio of death in PD patients with documented abdominal
catastrophe and peritonitis is reported to be 20:1 compared with all other causes. Further reductions
in PD-associated peritonitis mortality are likely to depend on earlier diagnosis and better management of intra-abdominal pathology. Presentation with hypotension, sepsis, lactic acidosis, and/or
elevation of peritoneal fluid amylase should raise immediate concern for “surgical” peritonitis.
Suspicion for visceral disease should also be high in patients with gram-negative, polymicrobial, and
fungal infection or those who fail to improve rapidly as judged by clinical signs and symptoms, cell
counts, and repeat cultures. Nonlocalizing physical examination and negative or nonspecific results of
abdominal computed tomography do not rule out serious intra-abdominal disease. Immediate
initiation of broad antibiotic coverage including for anaerobic infection is indicated when bowel
pathology is suspected. Urgent surgical consultation, with active discussion and participation by the
nephrologist, is advisable when visceral pathology is suspected and the patient is unstable or fails to
improve rapidly.
© 2006 by the National Kidney Foundation, Inc.
Index Words: Peritoneal dialysis; Peritonitis; Enteric disease; Gram-negative peritonitis; Polymicrobial
peritonitis

I

“

t was the best of times; it was the worst of
times.” Were Dickens a nephrologist, this
would likely be his current impression of peritoneal dialysis (PD)-associated peritonitis.
Twenty-five years ago, most continuous ambulatory peritoneal dialysis programs reported peritonitis rates in excess of 1 to 2
episodes per patient year.1,2 By contrast, recent International Society for Peritoneal Dialysis guidelines3 state that all programs should
be able to achieve peritonitis rates of less than
0.67 infections per patient year at risk. Many
programs report rates of less than 0.3 infections per year.4,5 Decreases in the incidence of
Staphylococcus epidermidis infection can be directly traced to successive advances in connectology (eg, “Y” sets, twin bag sets, spikeless
connections, sterile connection devices, and
cyclers).6,7 Simultaneously, the widespread
use of anti-Staphylococcus prophylaxis (eg, nasal or exit-site mupirocin or exit-site gentamicin cream)8 –11 has dramatically reduced the
risk of Staphylococcus aureus peritonitis and
catheter infection. Unfortunately, mortality

because of peritonitis has not decreased in
parallel and still accounts for more than 15%
of reported deaths.12,13 The mortality of S epidermis peritoneal infection has been reported
as less than 1 percent,12 but deaths after S
aureus peritonitis have been reported in 3.4%14
to 15%13 of episodes. Moreover, although
Staphylococcus (and in some reports Pseudomonas) infections have indeed decreased,15 the
incidence of the peritoneal infections associated with the highest reported mortality
(gram-negative,14 enterococcal,14 fungal, and
polymicrobial13,16 peritonitis) has not decreased. Newman et al17 compared organismspecific peritonitis rates during 1988 to 1996 to
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the period from 1996 to 2000. The most impressive decrease was in S aureus peritonitis
(0.136-0.053 episodes per patient year). Other
non-Streptococcus gram-positive infections
also decreased (0.281-0.232 episodes per patient year). In contrast, the rates of enteric,
polymicrobial, Streptococcus, Candida, and Enterococcus infections each remained stable or
increased. The explanation for the poorer outcomes associated with these particular infections is incomplete. It is likely that bacterial
virulence factors are responsible in some infections (especially S aureus, fungal, and P
aeruginosa), whereas the association with enteric infection and “abdominal catastrophe”16,18 probably underlies the virulence of
most of the other organisms listed.
The most difficult decision that a physician
caring for a PD patient with peritonitis must
make is whether or not to request (or insist)
that a surgical colleague explore the patient
for the presence of intra-abdominal pathology. Despite its invasive nature and inherent
risk, laparoscopy or laparotomy in judiciously
selected patients may be the key opportunity
to further reduce peritonitis-associated deaths
in this population. This article will use the
terms abdominal catastrophe; surgical peritonitis; intra-abdominal, enteric, or visceral pathology; disease; injury; or perforation interchangeably and in reference to serious intraabdominal disease typically considered to be
an indication for surgical intervention. In contrast, “enteric organisms” as defined by Harwell et al18 are microorganisms typically residing in the gastrointestinal tract and include
Klebsiella, Enterobacteriaceae, Serratia, Escherichia coli, Proteus spp, Morganella spp,
Citrobacter spp, Enterococcus spp, and Bacteroides spp. They also include organisms not
always recognized as enteric in origin including viridans streptococci and Torulopsis. Published experience makes it abundantly clear
that peritonitis associated with visceral injury
in PD patients entails high mortality,16 although the issue is confused by various reports defining “enteric,” “intrinsic,” or “endogenous” peritonitis according to the results
of dialysate cultures rather than documented
visceral injury or infection.
Other new challenges face PD patients and
the physicians caring for them today. The

increasing incidence of antibiotic-resistant microorganisms (including methicillin-resistant
S aureus and S epidermis and vancomycinresistant Enterococcus) further complicates empiric therapy of peritonitis.15,19 This may increase the risk of poor outcomes if effective
therapy is delayed by incorrect initial antibiotic choice. This review will explore in detail
the overlapping clinical issues that arise in PD
patients with gram-negative peritonitis,
polymicrobial peritonitis, and suspected or
presumed “abdominal catastrophe” and then
outline a treatment approach. The reader is
referred to several recent excellent reviews
and treatment guidelines that address routine
aspects of prevention, diagnosis, and treatment of peritonitis.3,20 –25

Gram-Negative Peritonitis
Overall reported mortality directly associated
with a PD-related peritonitis episode has generally been reported to range from 2% to 6%
13,26
(Table 1). Multiple reports make it clear,
however, that gram-negative peritonitis contributes disproportionately to mortality.
Bunke et al27 reported 6.5% mortality in PD
patients with Pseudomonas peritonitis (v 2.4%
in all other cases). They later compared the
mortality associated with non-Pseudomonas
gram-negative peritonitis to that of gram-positive infection.14 Although mortality of nonPseudomonas gram-negative infection was
higher than for S epidermidis peritonitis (3.7% v
0.8%), it was similar to that of S aureus (3.4%)
and lower than that of Enterococcus spp (7.4%).
Rates of catheter removal and transfer to hemodialysis were somewhat higher for nonPseudomonas gram-negative infection than for
S aureus, especially in the absence of exit-site
or tunnel infection. Fried et al12 reported that
death resulted in 9.5% of all gram-negative or
fungal episodes. Similarly, Perez-Fontan et
al13 reported 19.3% mortality in association
with infection by “enteric” organisms. Although not reporting organism-specific mortality rates, Kern et al16 reported an odds ratio
of death of 20.7:1 (95% confidence interval,
2.40-178.5) in patients with gram-negative
peritonitis compared with gram-positive infection.
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Table 1. Reported Outcomes of Gram-negative PD-Associated Peritonitis
Reference
No.

Author, Year

Microbiology

Gram-Negative
Mortality

Confirmed
Abdominal
Pathology

27

Bunke, 1995

Pseudomonas spp

6.5%

Not reported

12

Fried, 1996

Not reported

Bunke, 1997

All gram-negative or
fungal
Non-Pseudomonas
Gram-negative

9.5%

14

3.7%

3/136 (2.2 %)

16

Kern, 2002

Single gram-negative

51

Prasad, 2003

13

Perez-Fontan,
2005

Single gram-negative
(66% “fecal”
origin)
Enterobacteriaciae
Pseudomonas spp
Other gram-negative

Odds Ratio
20.7 (CI 2.4–
178.5)
20%

4.7%
11.1%
0%

56%

Not reported

Not reported

Reference Group
Mortality

Other Gram-negative Long
Term Outcomes

Non-Pseudomonas
gram-negative
(2.4%)
S epidermidis (0.5%)
Other (2.5%)
S epidermidis (0.8%)
S aureus (3.4%)
Enterococcus spp (7.4%)
Gram-positive

Catheter loss 61%, switch
to HD 26%

Single gram-positive
(10%) (53% “fecal”
origin)
S epidermidis (0.5%)
S aureus (15.2%)
Enterococcus spp (7.4%)

Catheter loss 30%, switch
to HD 14%
Catheter loss 30%, switch
to HD 14%
Catheter loss 37%
Switch to HD 8.9%

Abbreviation: HD, hemodialysis.

Polymicrobial Peritonitis
28

Szeto et al reported on 140 episodes of
polymicrobial peritonitis in 112 patients (Table 2). The full spectrum of possible microbiological mixes was represented, including
only gram-positive organisms (28%), mixed
gram-positive and gram-negative infection
(24%), only non-Pseudomonas gram-negative
organisms (9%), Pseudomonas (11%), and fungal infections (21%). Ninety episodes (64%)

responded to antibiotic therapy alone. Approximately 70% of patients remained on or
returned to peritoneal dialysis after resolution. The clinical algorithm used in Szeto et
al’s report was to consider laparotomy and/or
catheter removal only if infection failed to
respond after 10 days of appropriate antibiotic
therapy. Thus, although the authors assumed
that all of these cases were caused by some
type of abdominal visceral perforation, ex-

Table 2. Reported Outcomes of Polymicrobial PD-Associated Peritonitis
Reference
No.
32

29

Author, Year
Van der
Reijden,
1988
Holley, 1992

Microbiology
“Enteric” (2 or more
gram-negatives, most
with Bacteroides)
Enteric and nonenteric

Polymicrobial
Mortality

Confirmed
Abdominal
Pathology

6.9% of
episodes

Kiernan, 1995 Gram-positive,
Gram-negative,
And/or fungal
Suh, 1996
“Enteric” (2 or more
gram-negatives)

5% immediate
13.7% at 6 mos

7.5% of
episodes

31

Kim, 2000

Gram-positive,
Gram-negative,
And/or fungal

11% at 3 years

28

Szeto, 2002

Gram-positive,
Gram-negative,
And/or fungal

9% immediate
15% at 3 months

13

Perez-Fontan, Nonenteric polymicrobial
2005
Enteric polymicrobial

33

Long-Term Outcomes

57% by 13 days
72% at 2 months
2.6% of patients

30

Reference Group
Mortality

Catheter removal 40%
Hemodialysis transfer
16%

13%

4.5%
19.4%

Abbreviations: HD, hemodialysis; PD, peritoneal dialysis.

7% of patients Single organism
(33% 3 years)
No peritonitis
(36% 3 years)
4.4%

S epidermidis (0.5%)
S aureus (15.2%)
Enterococcus spp (7.4%)

33% still on PD
38% develop fungal
peritonitis despite
prophylaxis
70% transfer to HD at
last follow-up (33
⫾ 26 mos)
90% response
to antibiotics;
70% remain on or
return to PD
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Table 3. Reported Outcomes of PD-Associated Peritonitis With Confirmed Visceral Injury
Reference
No.
18

16

Author, Year
Harwell,
1997
Kern, 2002

Microbiology

Mortality

Single enteric 22/26
Polymicrobial 3/26
Single Gram-negative 58.5% in confirmed
visceral injury (11.8% other etiologies
of peritonitis)
Polymicrobial ⬍ 20%
OR. of enteric infection 66:1 (CI
7.9 –551.3)
in patients with gram-negative
peritonitis
OR of enteric infection 22:1 (CI 1.6 –315.1)
in patients with fungal peritonitis

46.3% enteric peritonitis
7.5% other peritonitis
OR of death 20.1
(CI 5.4 –75.2) with
peritonitis because
of documented
visceral injury,
41.5 (CI 5.5–317.5)
with peritonitis
because of sepsis

Abbreviations: OR, odds ratio; CI, confidence interval.

ploratory laparotomy was performed in only
8 cases. Intra-abdominal pathology was confirmed in only 3 of these surgical explorations
(strangulated hernia, ischemic colitis with perforation, and sigmoid colon carcinoma). Unfortunately, another 13 patients (9%) died before surgical exploration was performed. Of
these 13 early deaths, severe peritonitis was
the direct etiology in 9. Seven of these 9 underwent postmortem examination, during
which only 1 case of bowel pathology (perforated colonic diverticulum) was found. Another 8 patients died subsequently of various
causes within 3 months. Thus, although total
3-month mortality was 15%, it is unclear what
percentage of these patients had visceral disease and whether earlier operative intervention (laparotomy and/or catheter removal)
would have reduced total mortality or that
caused directly by peritonitis.
Three earlier, smaller published series of
PD patients with polymicrobial peritonitis29 –31 reported similar findings. Specific intra-abdominal pathology was documented in
only 7% of cases, although most patients were
not specifically investigated. Deaths immediately attributable to peritonitis were infrequent (3.7%), although eventual mortality was
still appreciable. For example, Kiernan et al30
reported only 4 deaths directly attributable to
80 polymicrobial peritonitis episodes but another 7 deaths in the following 6 months (total
mortality, 14%). Interestingly, Kim and Korbet31 reported that patients with polymicrobial peritonitis had higher survival (91% at 3

years) than either patients with single organism peritonitis (67%) or patients without peritonitis (37%). Nevertheless, long-term technique survival was extraordinarily low after
polymicrobial infection (30% at last follow up,
averaging 33 ⫾ 26 months).
The experience of Kern et al16 was substantially different, in that abdominal catastrophe
was documented in 73% of polymicrobial
peritonitis episodes in their report. Mortality
for this specific subset was not calculated but
was 46.3% for the entire group of patients
with abdominal catastrophe. In summary,
with the exception of Kern et al’s report, the
published predictive value of polymicrobial
infection for injury of the abdominal viscera is
generally low, especially for serious disease
requiring operative intervention. Nonetheless,
these patients appear to be at high risk over
time for either technique failure (primarily
attributed to recurrent peritonitis) or mortality.

Peritonitis Because of Visceral
Pathology or Abdominal Catastrophe
Van der Reijden et al32 defined “fecal” peritonitis by the presence of 2 or more gram-negative organisms in dialysate cultures, although most cultures also contained
Bacteroides species (Table 3). Three patients
recovered uneventfully after antibiotic treatment and PD catheter removal. In contrast, 4
others (57%) suddenly deteriorated 1 to 13
days after presentation and died despite even-
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tual surgical exploration and treatment for
sepsis and bowel perforation. One additional
patient survived surgical exploration immediately on identification of anaerobic organisms
but died 2 months later. Most of the documented cases were caused by perforation of
the sigmoid colon. By using a similar definition, Suh et al33 reported on 15 patients with
“endogenous” peritonitis, representing 7% of
all peritonitis episodes. Most of these cases
were preceded by severe constipation, and
most of the documented cases were caused by
ruptured colonic diverticulae. All patients received appropriate antibiotic therapy and antifungal prophylaxis. Three patients required
colectomy and colostomy, and another patient
required cholecystectomy. There were only 2
deaths (13%), including 1 of the colectomy
patients and another who refused surgery.
However, only 5 patients ultimately remained
on PD. Despite fluconazole prophylaxis, six
patients (38%) required catheter removal due
to subsequent fungal peritonitis after a mean
of 11 days (range, 3-24 days).
A comprehensive report by Harwell et al18
shows that confirmed visceral injury is not a
rare event in the PD population. They found
that abdominal catastrophe occurred once in
153.1 patient months in PD patients (cumulative incidence, 11.3% of patients) compared
with an estimated once in 10,000 patient
months on hemodialysis and 2,892 patient
months in kidney transplant recipients. This
report also documents the difficulty of assigning the etiology of peritonitis solely by the
result of dialysate cultures. The probable
cause of each of 354 peritonitis episodes that
occurred in 132 patients was determined.
Ninety-eight patients (43%) had no peritonitis.
A single enteric organism was isolated in 22 of
26 final peritonitis episodes attributable to
confirmed visceral injury. Polymicrobial infection was present in only 3 cases. There were 11
instances of ischemic bowel, 3 of gangrenous
cholecystitis, 6 of ruptured diverticular disease, 4 of appendicitis, and 1 case of perforated pyloric ulcer. These patients represented
19.7% of all patients with peritonitis and 11%
of all patients on PD. Moreover, documented
enteric injury accounted for only 32.5% of
peritonitis cases caused by enteric organisms,
whereas catheter-related infection and tech-
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nique failure together accounted for 42.5% of
infections with “enteric” pathogens.
There is another sobering observation from
these authors. Fifty percent of the 26 patients
with documented visceral injury died, constituting 33 percent of the episodes with documented
enteric disease. This mortality rate is similar to
that observed in earlier series of peritonitis resulting from visceral pathology.34 –36 Clearly, although some of the reports cited above may
provide support for a sanguine or “wait and
see” attitude about apparently stable patients
with gram-negative or polymicrobial peritonitis,
this is inadequate for patients with discernable
intra-abdominal pathology. Harwell’s initial report experience was updated in 2002.16 The update adds considerable new information. Anatomically documented abdominal catastrophe
can be segregated into higher- and lower-risk
groups, at least in the setting of heightened
awareness and surveillance for the condition,
coupled with early intervention when suspected. Of the 16 patients who developed documented abdominal catastrophe from 1996 to
2000, no patient with gallbladder or diverticular
disease died, and most returned to PD after
recovery. One patient with a perforated duodenal ulcer and both patients with strangulated
hernias recovered and remained on PD as well.
In contrast, despite timely operative intervention, all 5 patients with diffuse ischemic gastritis,
enteritis, or colitis died. Two other patients with
perforated peptic ulcer also died. Conceivably,
the outcome of even the lower-risk group might
have been worse without the proactive approach that was adopted.

Diagnosis of Abdominal Catastrophe
A suggested diagnostic approach to PD-associated peritonitis is shown in Figure 1. The
initial step is clinical evaluation (history and
physical examination) and collection of peritoneal effluent for gram-stain, culture and
sensitivity, and amylase concentration. The
presence of visceral injury is seldom certain at
the time a PD patient presents with peritonitis, with the exception of acute bowel perforation during peritoneoscopic catheter placement.37 Suspicion may be high earlier for
specific clinical disorders, such as mesenteric
ischemia in patients with known or suspected
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PD patient with peritonitis (abdominal pain,
cloudy effluent)
Dialysate sample for Gram-stain,
culture & sensitivity, amylase;

Clinically unstable
(SIRS, hypotension,
lactic acidosis, or septic syndrome)

Clinically Stable
Broad Gram-positive and Gramnegative coverage

Steady clinical improvement
Repeat dialysate culture sterile
(48 hrs) and
Repeat dialysate cell count near
normal (72 hrs)

Continue antibiotic therapy
according to culture and
sensitivity

Early goal directed resuscitati
resuscitation
Vancomycin, Gram-negative + anae
anaerobic
CT abdomen, blood cultures

Persistent infection or
inflammation (48-72 hours)

S. epidermidis
S. aureus
No growth
Possible catheter
Infection
Consider simple
catheter removal

Polymicrobial, yeast, anaerobic,
Gp D Strep, Gram-negative
Possible/probable abdominal
catastrophe
Add anerobic (and fungal if
appropriate) coverage
Laparotomy/laparoscopy
Nonspecific CT abdomen
Generalized peritonitis
Normal dialysate amylase

Possible/probable
abdominal catastrophe

No identifiable
extraabdominal
source

Extraabdominal source
identified

Secondary (hematogenous
or contiguous) peritonitis
Surgical disease
on CT abdomen,
localized peritoneal
irritation, or elevated
dialysate amylase

Treat underlying disease

Abdominal catastrophe
Emergency laparotomy or
laparoscopy

Rapid (12-24 hours)
clinical improvement

Persistent instability
(> 12-24 hours)

Fig 1. Algorithm for identification and management of suspected visceral disease in PD patients with
peritonitis. Perforated box, diagnostic testing or medical therapy decision; dotted box, surgical therapy
decision; solid arrow, diagnostic conclusion; perforated arrow, potentially unstable, monitor closely for
clinical deterioration.

vascular disease, and typical laboratory features such as elevation of serum lactate and
lactate dehydrogenase (LDH). Other clinical
disorders, such as appendicitis, cholecystitis,
or diverticulitis, may be suspected because of
localized peritoneal irritation in the corresponding location. However, this is not a reliable finding (vide infra), and lack of localized abdominal tenderness does not rule out
the presence of localized intra-abdominal disease. Presentation with septic shock or bacteremia is also distinctly uncommon and should
raise the suspicion of serious intra-abdominal
pathology if this occurs. More commonly, the
suspicion grows over days as culture results
confirming gram-negative, polymicrobial, anaerobic, and/or fungal infection become available. Culture results may suggest but seldom
prove the presence of visceral injury. Kern et
al16 reported the odds ratio of a patient having
visceral peritonitis as 66:1 in patients with
gram-negative or fungal organisms in dialysate culture compared with patients with
gram-positive infection. Yet, as discussed ear-

lier, only 56% of gram-negative and 33% of
fungal infections were of documented enteric
origin. Simultaneously, the patient may fail to
improve clinically, peritoneal leukocyte
counts may remain elevated, and dialysate
gram stain or cultures may continue to show
microorganisms. The consequence of late recognition can be disastrous. At worst, the diagnosis is made during a postmortem examination.
There are multiple reasons for the typical
delay in diagnosis of abdominal catastrophe
in PD patients. First, there is generally a low
index of suspicion. Nephrologists and surgeons alike often assume that peritonitis in a
PD patient is because of touch contamination
or periluminal (tunnel) infection. This is compounded by apparent alterations in PD patients of the natural history of conditions that
result in an acute abdomen. The ongoing
treatment with antibiotics masks without necessarily eradicating ongoing peritoneal contamination, whereas the presence of peritoneal fluid and the performance of peritoneal
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flushes obscure the localizing signs that might
suggest bowel pathology. Moreover, common
imaging studies have decreased sensitivity
and specificity in PD patients. The clinical
significance of pneumoperitoneum, a key diagnostic feature of intestinal perforation in the
general population, appears to be low in PD
patients, unless a large amount of air is
present.38 – 40 A computed tomography scan is
commonly negative in the face of proven abdominal pathology, which may result in further delays because of a false sense of security.
Peritoneal fluid amylase41,42 has been reported to distinguish between routine “nonsurgical” peritonitis (mean, 11 IU/L; range,
0-90 IU/L) and that associated with pancreatitis (mean, 540; range, 100-1,140) or bowel
perforation (mean, 816; range, 142-1,746).
Routine use of this assay in PD patients with
peritonitis might speed the diagnosis of serious abdominal pathology but has not been
tested prospectively.

Management of Suspected Abdominal
Visceral Pathology or Abdominal
Catastrophe in PD Patients
Fortunately, the routine gram-negative and
gram-positive antibiotic coverage for peritonitis outlined in recent International Society for
Peritoneal Dialysis guidelines3 covers the vast
majority of aerobic bacteria likely to be isolated from dialysate even in patients with
abdominal catastrophe (Fig 1). The major therapeutic void left by the typical regimen of
vancomycin or cefazolin, plus a third- or
fourth-generation cephalosporin or aminoglycoside, is anaerobic gram-negative and grampositive coverage. Consequently, when visceral injury is suspected, the addition of
intravenous metronidazole, piperacillin/tazobactam or other antianaerobic antibiotic is
mandatory. This suspicion generally arises because of clinical presentation, the results of
dialysate cultures, or failure to improve in a
timely fashion. Clindamycin is another antibiotic classically used for its anaerobic properties, but clinicians considering its use in this
setting should be aware of growing resistance
to it by Bacteroides fragilis among other organisms.43– 45
The nephrologist’s responsibility does not
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end, however, with the appropriate antibiotic
prescription or even with the request for a
surgical consultation. The patient’s clinical
progress requires close observation. Persistence of moderate to severe peritoneal inflammation, positive effluent cultures, or failure of
peritoneal cell counts to dramatically improve
within 48 to 72 hours should prompt strong
suspicion of either catheter or tunnel infection
or undiagnosed visceral injury. The distinction, of course, is critical, because simple catheter removal in addition to an appropriate
antibiotic regimen is sufficient in almost all
cases of the former,46 whereas intra-abdominal exploration with intervention appropriate
to the specific diagnosis is required in the
latter case. As discussed earlier, the presence
of “enteric” organisms supports, but does not
prove, the presence of visceral injury. Even
experienced surgeons may have little experience with PD patients and be unfamiliar with
the published experience relating to the assessment of the patients for abdominal catastrophe and the poor outcome associated with
specific types of visceral injury in PD patients.
Furthermore, they may be understandably
hesitant at the idea of laparotomy or even
laparoscopy in an acutely ill PD patient with
multiple cardiovascular risk factors, peritoneal effluent cultures that may have become
negative during antibiotic therapy, and a negative or nonspecific abdominal computed tomography scan. The authors are aware of
cases of ruptured appendicitis, perforated sigmoid colon, or gangrenous cholecystitis in
whom definitive surgery was delayed from 3
days to 3 weeks in these circumstances. After
obtaining the appropriate diagnostic studies,
it is critical that a nephrologist who suspects
an abdominal catastrophe carefully review the
data with the consulting surgeon, sharing any
pertinent personal experience and literature.
Experience shows that patients are best served
by this type of joint discussion between nephrologists and surgeons regarding the need for
catheter removal and/or surgical exploration
in the PD patient with peritonitis. When serious disagreement persists, a surgical second
opinion should be strongly considered.
Finally, as overall peritonitis rates decrease
and wait times for deceased donor kidney transplants continue to lengthen, patients are remain-
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ing on PD for increasingly longer durations.
Long duration on PD, along with high or rapid
transporter status, is the major risk factor for the
catastrophic and generally fatal complication of
encapsulating peritoneal sclerosis (EPS).47– 49
The most common event preceding the development EPS is sudden discontinuation of PD. It
has been suggested that long-term (more than 5
to 6 years) PD patients continue to flush the
peritoneum periodically for 6 to 12 months to
reduce the risk of subsequently developing
EPS,50 although the efficacy of this approach has
not been tested in a prospective, randomized
trial. It has also been suggested that if long-term
PD patients survive a catastrophic episode of
peritonitis, a new PD catheter should be inserted as soon as possible to enable resumption
of peritoneal lavage, although this is often not
immediately possible.
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